SCHEMBL7274765

SCHEMBL7274765

CC(=O)/C(=C/c1ccccc1C(F)(F)F)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 1/20 0.50
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
HIF1A Q16665 1/20 0.48
MAOB P27338 7/20 0.47
LMNA P02545 3/20 0.43
P4HB P07237 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.42
MEN1 O00255 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MAOA P21397 1/20 0.40
BACE1 P56817 1/20 0.40
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GRIN1 Q05586 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7316254 1.00 NFKB1 (0.50) NFKB1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL7274769 1.00 NFKB1 (0.50) NFKB1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL9315407 0.92 NFKB1 (0.54) NFKB1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL8054505 0.83 NFKB1 (0.53) NFKB1MAOBLMNAP4HBABCG2
SCHEMBL8054503 0.83 NFKB1 (0.53) NFKB1MAOBLMNAP4HBABCG2
SCHEMBL9386421 0.83 MAPT (0.48) NFKB1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL10481034 0.83 MAPT (0.48) NFKB1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL10744797 0.83 MAPT (0.48) NFKB1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL10785285 0.80 MEN1 (0.53) NFKB1CYP1A2CYP2C9CYP2C19MAOB
SCHEMBL7318008 0.80 MEN1 (0.53) NFKB1CYP1A2CYP2C9CYP2C19MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5202330-A Hypotensive and cardiovascular agent, reduces blood pressure in mammals E. R. SQUIBB & SONS, INC. (US) 1993-04-13 US disclosed
EP-0237347-B1 1,2,3,4-Tetrahydro-6-substituted-4-aryl (or heterocyclo)-3-[(substituted amino)carbonyl]-2-thioxo (or oxo)-5-pyrimidinecarboxylic acids and esters E.R. Squibb & Sons, Inc. (US) 1991-06-12 EP disclosed
US-4855301-A 1,2,3,4-Tetrahydro-6-substituted-4-aryl(or heterocyclo)-3-((substituted amino)carbonyl)-2-thioxo (or oxo)-5-pyrimidinecarboxylic acids and esters E. R. SQUIBB & SONS, INC. (US) 1989-08-08 US disclosed
US-4728652-A VASODILATORS E. R. SQUIBB & SONS, INC. (US) 1988-03-01 US disclosed
EP-0237347-A2 1,2,3,4-Tetrahydro-6-substituted-4-aryl (or heterocyclo)-3-[(substituted amino)carbonyl]-2-thioxo (or oxo)-5-pyrimidinecarboxylic acids and esters E.R. Squibb & Sons, Inc. (US) 1987-09-16 EP disclosed
US-4654335-A CARDIOVASCULAR AGENTS E. R. SQUIBB & SONS, INC. (US) 1987-03-31 US disclosed
EP-0208964-A2 1,5-Benzothiazepine compounds E.R. Squibb & Sons, Inc. (US) 1987-01-21 EP disclosed
EP-0204317-A2 2-Thio or oxo-4-aryl or heterocyclo-1,5(2H)-pyrimidinedicarboxylic acid diesters and 3-acyl-5-pyrimidinecarboxylic acids and esters E.R. Squibb & Sons, Inc. (US) 1986-12-10 EP disclosed
EP-0202654-A2 5-Carboxy-1,4-dihydropyrimidine derivatives E.R. Squibb & Sons, Inc. (US) 1986-11-26 EP disclosed